Cardiac Issues Associated with High-Dose Drug Trial

Last week, Teva Pharmaceutical Industries Ltd. and Active Biotech AB announced they were ending the higher-dose portions of two multiple-sclerosis medication studies. The decision came after eight patients suffered nonfatal… Read More

First Up for Google Life Sciences–Tackling Diabetes

Last month, Google announced that it was creating a new holding company called Alphabet and spinning off all non-core activities from the Google brand–including life sciences work inside Google X…. Read More

Merck Beats Earning Estimates

Merck & Co., the second largest U.S. drug maker by sales, beat earnings estimates after they a cut in promotions and research spending. First-quarter profits were 88 cents a share,… Read More

What is driving pharmaceutical shortages?

By Maureen Aylward The Washington Post reports that there is a serious drug shortage of several important pharmaceuticals. We looked to our Zintro experts to tell us what is happening… Read More